Sitagliptin Phosphate (50mg) & Metformin HCI (500mg)
GLISITAPTIN M 500 is a combination medication widely prescribed for managing Type 2 Diabetes Mellitus. The tablet combines two active ingredients: Sitagliptin Phosphate (50mg) and Metformin HCl (500mg). Together, these ingredients work synergistically to regulate blood sugar levels, improve insulin sensitivity, and help patients maintain optimal glucose control throughout the day.
Composition:
Sitagliptin Phosphate: 50mg
Metformin HCl: 500mg
Key Features and Ingredients
Sitagliptin Phosphate (50mg)
Sitagliptin Phosphate is a DPP-4 inhibitor (Dipeptidyl Peptidase-4), which works by increasing the levels of incretin hormones. These hormones help regulate insulin secretion and control blood sugar levels after meals. By blocking the action of the DPP-4 enzyme, Sitagliptin prevents the rapid breakdown of incretin hormones, promoting enhanced glucose-dependent insulin secretion, and reducing the release of glucagon (a hormone that increases blood sugar).
Metformin HCl (500mg)
Metformin HCl is a widely used biguanide class medication that helps lower blood sugar levels by:
Reducing glucose production in the liver.
Improving insulin sensitivity in muscle and fat cells, which enhances glucose uptake.
Decreasing intestinal absorption of glucose, thereby lowering postprandial (after-meal) blood sugar spikes.
Together, these ingredients in GLISITAPTIN M 500 help achieve better glucose control with minimal risk of hypoglycemia (low blood sugar levels).
Usage
GLISITAPTIN M 500 is primarily used for:
Managing Type 2 Diabetes: It is indicated for patients who need more than one drug to manage their blood glucose levels when diet and exercise alone are insufficient.
Adjunct to Lifestyle Modifications: In addition to diet and exercise, it is often used when blood sugar is not adequately controlled by other oral medications.
Improved Postprandial Glucose Control: It helps in controlling postprandial glucose spikes, which is critical for individuals struggling with fluctuating blood sugar after meals.
How to Use:
The recommended dose of GLISITAPTIN M 500 is one tablet once a day, typically taken with meals to reduce the risk of stomach upset.
The dose may be adjusted depending on the patient’s blood sugar levels and tolerance. Always follow your healthcare provider’s instructions for proper dosage.
Benefits
1. Enhanced Blood Sugar Control
The combination of Sitagliptin and Metformin offers a dual action approach to managing blood sugar:
Sitagliptin helps regulate insulin secretion and reduces glucagon levels.
Metformin decreases glucose production and increases insulin sensitivity, thereby reducing insulin resistance.
Together, they improve overall glycemic control, lowering both fasting and postprandial blood sugar levels.
2. Weight Neutral or Mild Weight Loss
Unlike some diabetes medications that can cause weight gain, GLISITAPTIN M 500 has been shown to be weight-neutral or may even help in mild weight loss. This is particularly beneficial for patients with Type 2 Diabetes who may struggle with obesity, a common comorbidity.
3. Reduced Risk of Hypoglycemia
GLISITAPTIN M 500 has a lower risk of causing hypoglycemia (low blood sugar) compared to some other oral diabetic medications. Since it works by improving the body’s natural insulin response, the risk of dangerously low blood sugar is minimized, especially when taken as prescribed.
4. Convenience of Combined Therapy
With Sitagliptin and Metformin in a single pill, GLISITAPTIN M 500 reduces the number of medications that need to be taken, offering better adherence to treatment.
5. Long-Term Benefits
Both ingredients in GLISITAPTIN M 500 contribute to long-term benefits for individuals with Type 2 diabetes. Metformin helps in improving insulin sensitivity over time, while Sitagliptin contributes to better overall glucose control. Combined, they work to reduce the risk of diabetes-related complications, such as cardiovascular diseases, kidney issues, and nerve damage.
Conclusion
GLISITAPTIN M 500 is a highly effective and well-tolerated medication for individuals with Type 2 Diabetes Mellitus. By combining Sitagliptin Phosphate 50mg and Metformin HCl (500mg), this combination therapy works to regulate blood sugar, reduce post-meal glucose spikes, and improve overall glycemic control. Its dual mechanism of action, along with its weight-neutral effects and low risk of hypoglycemia, make it an excellent choice for managing Type 2 Diabetes effectively.
For further information
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 8209542042 , 8824175417
